Simon M Mueller
ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.
Cerminara S, Cvijetic I, Huber S, Mueller S, Kostner L, Goessinger E, Narainsing J, Dutilh G, Heidemeyer K, Yawalkar N, Conrad C, Plaza T, Maul J, Cozzio A, Navarini A. ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis. J Eur Acad Dermatol Venereol 2024
24.10.2024ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.
24.10.2024J Eur Acad Dermatol Venereol 2024
Cerminara Sara Elisa, Cvijetic Ivana, Huber Stephanie, Mueller Simon M, Kostner Lisa, Goessinger Elisabeth V, Narainsing Jasmin, Dutilh Gilles, Heidemeyer Kristine, Yawalkar Nikhil, Conrad Curdin, Plaza Tobias, Maul Julia-Tatjana, Cozzio Antonio, Navarini Alexander A
Topical corticosteroid concerns from the clinicians' perspective
Mueller S, Tomaschett D, Vogt D, Itin P, Cozzio A, Surber C. Topical corticosteroid concerns from the clinicians' perspective. J Dermatolog Treat 2016:1-5.
07.12.2016Topical corticosteroid concerns from the clinicians' perspective
07.12.2016J Dermatolog Treat 2016:1-5
Mueller Simon M, Tomaschett Dominique, Vogt Deborah R, Itin Peter, Cozzio Antonio, Surber Christian